4 completed, 1 not yet recruiting, 1 terminated. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Adjuvant: new trials by email Literature Review of Adjuvant trials Research Report on Adjuvant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B TVAX-028, Adjuvant - HBV Infection | Phase 1 | Not yet recruiting | Grand Theravac Life Sciences (Nanjing) Co., Ltd. | 32 | 2026-05-31 | 2026-06-29 |
| The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults SCTV01C, Adjuvant, Saline - COVID-19 | Phase 1 / Phase 2 | Completed | Sinocelltech Ltd. | 478 | 2021-12-01 | 2024-02-08 |
| A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma NEO-PV-01, Nivolumab, Adjuvant - Metastatic Melanoma | Phase 1 | Terminated | BioNTech US Inc. | 22 | 2018-10-08 | 2020-09-03 |
| A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer NEO-PV-01, Pembrolizumab, Adjuvant - Carcinoma, Non-Small-Cell Lung, Lung Cancer | Phase 1 | Completed | BioNTech US Inc. | 38 | 2018-05-04 | 2021-02-26 |
| A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer NEO-PV-01, Nivolumab, Adjuvant - Urinary Bladder Cancer, Bladder Tumors | Phase 1 | Completed | BioNTech US Inc. | 34 | 2016-10-01 | 2021-02-25 |
| Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant Fluzone vaccine with JVRS-100 adjuvant, Fluzone vaccine - Influenza | Phase 1 | Completed | Colby Pharmaceutical Company | 128 | 2008-06-01 | 2010-03-17 |
Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Melanoma (2) · COVID-19 (1) · Influenza, Human (1) · Skin Neoplasms (1) · Urinary Bladder Neoplasms (1)
BioNTech US Inc. (3) · Colby Pharmaceutical Company (1) · Grand Theravac Life Sciences (Nanjing) Co., Ltd. (1) · Sinocelltech Ltd. (1)
United States (4) · China (1)
Mark DeMario, MD (3) · Thomas P Monath, MD (1) · Yimin Cui, M.D. (1)